We evaluated 100 patients with chronic colpo-vaginitis treated with the immunotherapeutic Gynatren/SolcoTrichovac. 44 patients suffered from ‘non-specific’ vaginitis, 42 were infected with Candida albicans and 14 with Chlamydia vaginalis. All patients had had several episodes of vaginal infections, some of them over several years, and 53 patients had current infection which, despite treatment with various drugs and remedies, had already persisted more than 2 months. The treatment consisted of 3 intramuscular injections at intervals of 2 weeks. Four weeks after beginning treatment all patients were free from pain despite the fact that the immune response was not yet fully developed. Four weeks later 72 % were classified as cured or much improved and 6 months after beginning therapy 49 of the 89 patients examined at this time were cured and a further 11 patients presented with only ‘mild symptoms’.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.